title: Clinical application of antialdosterone-containing hormone therapy for postmenopausal women.
abstract: Increased awareness of the risk of cardiovascular disease (CVD) in postmenopausal women will aid clinicians in choosing the most appropriate hormone therapy (HT) for their patients. An antialdosterone-containing hormonal therapy offers postmenopausal women advantages beyond simply the relief of menopausal symptoms; drospirenone/estradiol therapy has a theoretical advantage for the modulation of postmenopausal cardiovascular target organ complications. Additionally, drospirenone/ estradiol therapy represents an attractive alternative to other forms of HT.
authors.affiliation: Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut, USA. maryjane.minkin@yale.edu
authors.forename: Mary Jane
authors.initials: MJ
authors.lastname: Minkin
mesh_terms: D000736:Androstenes / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D017698:Postmenopause / Q000187:drug effects*
chemical_list: D000736:Androstenes; D004338:Drug Combinations; D000451:Mineralocorticoid Receptor Antagonists; C035144:drospirenone